Physician profile
Eric S Silverman
NPI 1538275490
$1,205.04
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $263 · 2021: $236 · 2023: $61.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $459.71 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $331.76 | 2019-2023 | Breztri |
| Janssen Pharmaceuticals, INC | $87.05 | 2019-2023 | Xarelto |
| Genentech USA, INC. | $76.47 | 2019-2020 | |
| Genzyme Corporation | $47.68 | 2019 | |
| Sunovion Pharmaceuticals INC. | $45.21 | 2019 | |
| Grifols USA, LLC | $31.11 | 2019 | |
| Mylan Specialty L.P. | $30.27 | 2019-2020 | |
| Circassia INC. | $28.54 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $27.48 | 2021 | |
| Insmed, INC. | $23.71 | 2019 | |
| Amgen INC. | $16.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Silverman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.